Ma Doctor Chief Physician

Peking University Cancer Hospital · Chief Physician

Associate Chief Physician, Second Department of Thoracic Oncology, Peking University Cancer Hospital, Doctor of Clinical Medicine, Peking University Specialties: Focuses on medical treatment for common and rare types of lung cancer, malignant pleural mesothelioma, thymic carcinoma and other thoracic tumors. Specializes in comprehensive diagnosis and treatment including tumor targeted therapy, immunotherapy and novel drug therapies. Has participated in or led multiple domestic and international clinical trials as well as translational research on new anti‑tumor drugs.

Specializing in the medical treatment of common and rare types of lung cancer, malignant pleural mesothelioma, thymic carcinoma, and other thoracic tumors, with expertise in comprehensive diagnosis and treatment including tumor-targeted therapy, immunotherapy, and novel drugs. Involved in or responsible for multiple domestic and international clinical studies and translational research on new oncology drugs.

Ma Doctor
Basic Information

About Dr. Ma Doctor

Hospital
Peking University Cancer Hospital
Title
Chief Physician
Department
Years of Practice
28 years (1998 — present)

Associate Chief Physician, Department of Thoracic Oncology II, Peking University Cancer Hospital, Doctor of Clinical Medicine, Peking University.

 

Specialties: Focuses on the medical treatment of common and rare types of lung cancer, malignant pleural mesothelioma, thymic carcinoma and other thoracic tumors. Specializes in comprehensive diagnosis and treatment including tumor targeted therapy, immunotherapy and novel‑drug therapy. Has participated in or led multiple domestic and international clinical trials as well as translational research of new anti‑tumor drugs.

 

Academic Publications: Co‑authored Comprehensive Therapeutics for Elderly Lung Cancer. Presided over research projects funded by the Wu Jieping Medical Foundation and Beijing Cancer Prevention and Treatment Research Association. Has published numerous papers, including:

 

Prognostic factor analysis of patients with small cell lung cancer: Real‑world data from 988 patients. Thoracic Cancer. 2021 Jun;12(12).

 

Clinical outcomes of atezolizumab in combination with etoposide/platinum for treatment of extensive‑stage small‑cell lung cancer: A real‑world, multicenter, retrospective, controlled study in China. Chinese Journal of Cancer Research. 2022 Aug 30;34(4).

Schedule

Dr. Ma Doctor — Outpatient Schedule

Weekly clinic, including specialist and surgery days. Book 3-7 days in advance.

Clinic: Peking University Cancer Hospital · Department
On Duty
Off Duty
Period Morning
08:00-12:00
Afternoon
14:00-17:30
Evening
18:30-20:30
Mon Off Duty
13:30 - 17:00
Off Duty
Tue Off Duty Off Duty Off Duty
Wed Off Duty Off Duty Off Duty
Thu Off Duty Off Duty Off Duty
Fri Off Duty Off Duty Off Duty
Sat Off Duty Off Duty Off Duty
Sun Off Duty Off Duty Off Duty
Note: Actual clinic hours are subject to the hospital's daily notice. Please call the Dovecure 24h hotline 400-888-0000 to confirm before booking.

Rationale for Precision

Senior Medical Advisory Team — With an average of over five years of clinical experience, the team has supported over 1,000 families in accessing coordinated, high-quality medical care in China.

Book your dedicated advisor now

Senior Medical Advisory Team — With an average of over five years of clinical experience, the team has supported over 1,000 families in accessing coordinated, high-quality medical care in China.

Consult Now
24/7 medical consultation +86 18126771334 (iMessage)
Email Consultation cure@dovecure.com
WhatsApp WeChat QR Code WeChat QR Code
Cart
Your cart is empty
Continue shopping
{{ item.sku_code }} - {{ item.variant_label }} {{ item.item_type_label }}
{{ item.price_format }}
{{ item.subtotal_format }}
Total {{ totalAmount }}
Checkout View Cart
Consult